Julien Langrand-Escure

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

Astrid Lièvre, Anthony Turpin, Isabelle Ray‐Coquard et al. · European Journal of Cancer · 2020 · 164 citations · Full text

Medicine, Infectious Diseases, Oncology +14

Dose constraints for moderate hypofractionated radiotherapy for prostate cancer: The French genito-urinary group (GETUG) recommendations

Julien Langrand-Escure, R. de Crevoisier, C. Llagostera et al. · Cancer/Radiothérapie · 2018 · 26 citations

Medicine, Radiation Oncology, Urology +16

Safety assessment of molecular targeted therapies in association with radiotherapy in metastatic renal cell carcinoma

Julien Langrand-Escure, Alexis Vallard, Romain Rivoirard et al. · Anti-Cancer Drugs · 2016 · 23 citations

Medicine, Oncology, Radiation Oncology +17

Correlation between anthropometric parameters and acute skin toxicity in breast cancer radiotherapy patients: a pilot assessment study

Benoîte Méry, Alexis Vallard, Jane‐Chloé Trone et al. · British Journal of Radiology · 2015 · 20 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Outcomes prediction in pre-operative radiotherapy locally advanced rectal cancer: leucocyte assessment as immune biomarker

Alexis Vallard, Max-Adrien Garcia, Peng Diao et al. · Oncotarget · 2018 · 19 citations · Full text

Medicine, Oncology, Radiation Oncology +16